Acorda Therapeutics Inc(ACOR)
4.14
Change: 0 (0)
As of Wed 10/06/2021 03:01 AM% Of Value
Growth
Value Per Share
:
:
:
25.89
-15.62
15.9900 (as of 19/07/2019)
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
NO DATA TO DISPLAY
Fundamentals Data
| Open | 6.81 | Dividend | 45 |
| Close Price | 4.14 | DivYield | 0 % |
| High | 7.02 | Growth | 0.0 |
| Low | 6.72 | Growth% | -15.62 |
| P/e | 20.152 | Volume | 799,047.0 |
| P/b | -0.14 | Market Capital | 39.2 M |
| Highest High | 30.15 | Lowest Low | 13.8 |
| 50 Days Moving Average | 8.67 (as of 18/07/2019) | 50 Days Moving Average Percentage | -40.412 (as of 18/07/2019 |
| Industry: Biotechnology: Biological Products (No Diagnostic Substances) |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 588.2 M | 471.4 M | 192.4 M | 152.9 M | 129.0 M |
| Cap Spending | -13.6 M | -33.3 M | -90.4 M | -4.3 M | -165,000.0 |
| Operating Expenses | 645.0 M | 278.6 M | 556.1 M | 268.3 M | 165.5 M |
| Operating Cash Flow | -192.4 M | 93.5 M | -398.5 M | -148.9 M | -77.2 M |
| Free Cash Flow | 82.8 M | 117.4 M | -218.5 M | -65.3 M | -41.5 M |
| Free Cash Flow Per Share | 10.802 | 14.992 | -27.605 | -8.09 | -3.909 |
| Total liabilities | 335.1 M | 343.7 M | 249.6 M | 259.9 M | 190.9 M |
| Total cash | 307.4 M | 294.0 M | 105.1 M | 102.8 M | 65.2 M |
| ROE% | -0.348 | 0.057 | -0.641 | -0.347 | -0.584 |
| Outstanding Shares | 7.8 M | 7.9 M | 7.9 M | 9.4 M | 13.2 M |
| P/E | -5.387 | 20.152 | -0.253 | -0.562 | -0.217 |
| P/S | 2.045 | 1.44 | 0.359 | 0.366 | 0.175 |
| Revenue USD | 588.2 M | 471.4 M | 192.4 M | 152.9 M | 129.0 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|